These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3709536)

  • 1. Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin.
    Tronrud DE; Monzingo AF; Matthews BW
    Eur J Biochem; 1986 Jun; 157(2):261-8. PubMed ID: 3709536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues.
    Holden HM; Tronrud DE; Monzingo AF; Weaver LH; Matthews BW
    Biochemistry; 1987 Dec; 26(26):8542-53. PubMed ID: 3442675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases.
    Monzingo AF; Matthews BW
    Biochemistry; 1984 Nov; 23(24):5724-9. PubMed ID: 6395881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides.
    Hangauer DG; Monzingo AF; Matthews BW
    Biochemistry; 1984 Nov; 23(24):5730-41. PubMed ID: 6525336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of L-valyl-L-tryptophan to crystalline thermolysin illustrates the mode of interaction of a product of peptide hydrolysis.
    Holden HM; Matthews BW
    J Biol Chem; 1988 Mar; 263(7):3256-60. PubMed ID: 3343246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of the inhibition of thermolysin by an active-site-directed irreversible inhibitor.
    Holmes MA; Tronrud DE; Matthews BW
    Biochemistry; 1983 Jan; 22(1):236-40. PubMed ID: 6830761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues.
    Fraser ME; Strynadka NC; Bartlett PA; Hanson JE; James MN
    Biochemistry; 1992 Jun; 31(22):5201-14. PubMed ID: 1606144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analogue inhibitors of thermolysin.
    Bartlett PA; Marlowe CK
    Biochemistry; 1987 Dec; 26(26):8553-61. PubMed ID: 3442676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redetermination and refinement of the complex of benzylsuccinic acid with thermolysin and its relation to the complex with carboxypeptidase A.
    Hausrath AC; Matthews BW
    J Biol Chem; 1994 Jul; 269(29):18839-42. PubMed ID: 8034637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substances.
    Weaver LH; Kester WR; Matthews BW
    J Mol Biol; 1977 Jul; 114(1):119-32. PubMed ID: 909082
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiorphan and retro-thiorphan display equivalent interactions when bound to crystalline thermolysin.
    Roderick SL; Fournie-Zaluski MC; Roques BP; Matthews BW
    Biochemistry; 1989 Feb; 28(4):1493-7. PubMed ID: 2719912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermolysin-inhibitor complexes examined by 31P and 113Cd NMR spectroscopy.
    Gettins P
    J Biol Chem; 1988 Jul; 263(21):10208-11. PubMed ID: 3392009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of a mercaptan-thermolysin complex illustrates mode of inhibition of zinc proteases by substrate-analogue mercaptans.
    Monzingo AF; Matthews BW
    Biochemistry; 1982 Jul; 21(14):3390-4. PubMed ID: 7052122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding energetics of phosphorus-containing inhibitors of thermolysin.
    Grobelny D; Goli UB; Galardy RE
    Biochemistry; 1989 Jun; 28(12):4948-51. PubMed ID: 2765520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphonamidates as transition-state analogue inhibitors of thermolysin.
    Bartlett PA; Marlowe CK
    Biochemistry; 1983 Sep; 22(20):4618-24. PubMed ID: 6626519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of zinc substitutions in the active site of thermolysin.
    Holland DR; Hausrath AC; Juers D; Matthews BW
    Protein Sci; 1995 Oct; 4(10):1955-65. PubMed ID: 8535232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of silanediols as transition-state-analogue inhibitors of the benchmark metalloprotease thermolysin.
    Juers DH; Kim J; Matthews BW; Sieburth SM
    Biochemistry; 2005 Dec; 44(50):16524-8. PubMed ID: 16342943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding between thermolysin and its specific inhibitor, phosphoramidon.
    Kitagishi K; Hiromi K
    J Biochem; 1984 Feb; 95(2):529-34. PubMed ID: 6715312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
    Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and enzymatic evaluation of phosphoramidon and its β anomer: Anomerization of α-l-rhamnose triacetate upon phosphitylation.
    Sun Q; Yang Q; Gong S; Fu Q; Xiao Q
    Bioorg Med Chem; 2013 Nov; 21(21):6778-87. PubMed ID: 23988485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.